Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Christie NHS Foundation Trust
With
University of Manchester
Patients will be informed of the study and given a minimum of 24 hours to consider. Once consented patients will enter the study where they will take cytokine samples at home over a 12 week period.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Voluntary informed consent.
Aged at least 18 years.
Diagnosis of locally advanced or metastatic RCC, Melanoma or NSCLC
In the opinion of the investigator deemed suitable to receive first-line combination immunotherapy (RCC and MM) or combination immunotherapy and chemotherapy (NSCLC).
Willingness to comply with scheduled trial procedures.
Capable of performing own dry blood sampling procedure, or a carer who is willing and able to perform them.
You may not be if
Previous immunotherapy (including any CPI either as single agent on in combination, or high dose interleukin-2).
Judgement by the investigator that the individual should not participate if they are unlikely to comply with study procedures and requirements.
Patients receiving long term oral anticoagulation deemed by the clinician to be at risk from daily finger pricking.
Clareo Health | NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
